Published on: October 24, 2018 at 09:30PM
Conditions:   Type2 Diabetes;   Heart Failure
Interventions:   Drug: Ertugliflozin;   Drug: Placebo
Sponsors:   Soo Lim;   MSD Korea Ltd.
Not yet recruiting
https://ift.tt/2D0KsYX

0 Comments